Trius Therapeutics Inc — Form D

Trius Therapeutics Inc of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-07. The offering totals $44.3M, of which $30.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Brian G AtwoodDirectorGaithersburg, MD
Karin S EasthamDirectorSan Diego, CA
David S KabakoffDirectorSan Diego, CA
Nina S KjellsonDirectorPalo Alto, CA
Brenden R O'LearyDirectorNeedham, MA
Michael S PowellDirectorSan Francisco, CA
Theodore R SchroederDirectorSan Diego, CA
Risa P StackDirectorSouth San Francisco, CA
Jeffrey SteinDirectorSan Francisco, CA
Paul F TruexDirectorMilpitas, CA
Kenneth S BartizalExecutive OfficerSan Diego, CA
John FinnExecutive OfficerLouisville, CO
Michael R MorneauExecutive OfficerSan Diego, CA
Philippe S ProkocimerExecutive OfficerSan Diego, CA
John P SchmidExecutive OfficerSan Diego, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA
John SchmidExecutive OfficerSan Diego, CA
Risa StackDirectorBerkeley, CA
David KabakoffDirectorBrisbane, CA
Paul TruexDirectorSanta Clara, CA
Nina G KjellsonDirectorSan Diego, CA
Karin G EasthamDirectorSan Diego, CA
Philippe G ProkocimerExecutive OfficerSan Diego, CA
Michael G PowellDirectorSan Francisco, CA
Kenneth G BartizalExecutive OfficerSan Diego, CA

Other filings by this issuer (1)

FiledFormOfferingSold
2009-11-12D$30.0M$19.2M

More